Recent SEC filings revealed exactly how many shares of SpaceX Musk currently owns. That number is very important for ...

This proposed new package of rules would affect the fundraising ecosystem significantly.

"As we deliver our first $3 billion quarter in Q2 2026, it is clear that our Arista 2.0 platform strategy is compelling," ...

History says the market will eventually collapse, but this time does look different.

The nuclear start-up just proved it can build a reactor in 11 months. Selling electricity from one runs on a different ...

Bill Ackman, the founder and CEO of Pershing Square Capital Management, has an impeccable record, as his firm has ...

The memory giant is retiring roughly one share in every 30 -- and it says its shareholder-return target is moving from a ...

Axsome Therapeutics ( AXSM -0.13%), a biotech company, has performed fairly well this year. The company's shares are up 16% ...

The math behind Social Security's looming funding gap is becoming painfully real for retirees. Congress has known for years ...

This is a niche neither Eli Lilly nor Novo Nordisk targets, and it could make Rhythm Pharmaceuticals successful. Rhythm ...

My view is that Johnson & Johnson is a much better pick between these two companies right now. The pharmaceutical leader ...

Stanley Druckenmiller and Dan Loeb are two of Wall Street's most closely watched investors. Druckenmiller is a macro ...